Condition
Pediatric Heart Transplantation
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
75.0%
-11.6% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results75% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Completed3
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03386539Phase 3CompletedPrimary
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
NCT02904278Not ApplicableCompleted
Novel Mobile Device Application to Improve Adherence
NCT02752789CompletedPrimary
Impact of Allo- and Autoantibodies on Chronic Cardiac Allograft Function
NCT01005316TerminatedPrimary
Alloantibodies in Pediatric Heart Transplantation
Showing all 4 trials